{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:09:15Z","timestamp":1762542555314,"version":"3.40.5"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jcv.2016.06.013","type":"journal-article","created":{"date-parts":[[2016,6,23]],"date-time":"2016-06-23T03:48:39Z","timestamp":1466653719000},"page":"5-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Immune-based guidance of foscarnet treatment duration in a transplant recipient with ganciclovir-resistant cytomegalovirus infection"],"prefix":"10.1016","volume":"82","author":[{"given":"Janine","family":"Mihm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Leyking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Dirks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrun","family":"Smola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Fliser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urban","family":"Sester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5482-0002","authenticated-orcid":false,"given":"Martina","family":"Sester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7789-8563","authenticated-orcid":false,"given":"Heinrike","family":"Wilkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Rissland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2016.06.013_bib0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1523-1755.2004.00735.x","article-title":"Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival","volume":"66","author":"Sagedal","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.jcv.2016.06.013_bib0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2016.06.013_bib0015","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1097\/01.ASN.0000030141.41726.52","article-title":"Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection","volume":"13","author":"Sester","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jcv.2016.06.013_bib0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1172\/JCI8229","article-title":"Development of virus-specific CD4(+) T cells during primary cytomegalovirus infection","volume":"105","author":"Rentenaar","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jcv.2016.06.013_bib0025","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/ajt.13684","article-title":"The ABC of virus-specific T cell immunity in solid organ transplantation","volume":"16","author":"Sester","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2016.06.013_bib0030","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study","volume":"56","author":"Manuel","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2016.06.013_bib0035","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1111\/ajt.12480","article-title":"PD-1 analysis on CD28(\u2212) CD27(\u2212) CD4T cells allows stimulation-independent assessment of CMV viremic episodes in transplant recipients","volume":"13","author":"Dirks","year":"2013","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2016.06.013_bib0040","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/tri.12378","article-title":"Viral load, CMV-specific T-cell immune response and cytomegalovirus disease in solid organ transplant recipients at higher risk for cytomegalovirus infection during preemptive therapy","volume":"27","author":"Martin-Gandul","year":"2014","journal-title":"Transplant. Int."},{"key":"10.1016\/j.jcv.2016.06.013_bib0045","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/00007890-200105150-00018","article-title":"Levels of virus-specific CD4T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation","volume":"71","author":"Sester","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jcv.2016.06.013_bib0050","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1600-6143.2005.00871.x","article-title":"Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation","volume":"5","author":"Sester","year":"2005","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2016.06.013_bib0055","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1111\/j.1600-6143.2008.02279.x","article-title":"PD-1 expression and IL-2 loss of cytomegalovirus-specific T cells correlates with viremia and reversible functional anergy","volume":"8","author":"Sester","year":"2008","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2016.06.013_bib0060","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12447","article-title":"It\u2019s not too late: a proposal to standardize the terminology of late-onset cytomegalovirus infection and disease in solid organ transplant recipients","author":"Razonable","year":"2015","journal-title":"Transplant. Infect. Dis."},{"key":"10.1016\/j.jcv.2016.06.013_bib0065","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/tid.12408","article-title":"Two-year post-transplantation cytomegalovirus DNAemia in asymptomatic kidney transplant recipients: incidence, risk factors, and outcome","volume":"17","author":"Viot","year":"2015","journal-title":"Transplant. Infect. Dis."},{"key":"10.1016\/j.jcv.2016.06.013_bib0070","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs: oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jcv.2016.06.013_bib0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-3062.2011.00705.x","article-title":"Risk factors and clinical outcomes of cytomegalovirus disease occurring more than one year post solid organ transplantation","volume":"14","author":"Blyth","year":"2012","journal-title":"Transplant. Infect. Dis."},{"key":"10.1016\/j.jcv.2016.06.013_bib0080","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/eji.201243100","article-title":"Cytomegalovirus-specific T cells are detectable in early childhood and allow assignment of the infection status in children with passive maternal antibodies","volume":"43","author":"Ritter","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jcv.2016.06.013_bib0085","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jcv.2012.03.001","article-title":"Cytomegalovirus-specific T-cell immunity to assign the infection status in individuals with passive immunity: a proof of principle","volume":"54","author":"Schmidt","year":"2012","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jcv.2016.06.013_bib0090","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1399-3062.2008.00344.x","article-title":"Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation","volume":"11","author":"Cummins","year":"2009","journal-title":"Transplant. Infect. Dis."},{"key":"10.1016\/j.jcv.2016.06.013_bib0095","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijid.2014.06.009","article-title":"Trip to immunity: resistant cytomegalovirus infection in a lung transplant recipient","volume":"28","author":"Kneidinger","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jcv.2016.06.013_bib0100","first-page":"4560745","article-title":"Treatment of cytomegalovirus infection with cidofovir and CMV immune globulin in a lung transplant recipient","volume":"2016","author":"Wilkens","year":"2016","journal-title":"Case Rep. Transplant."},{"key":"10.1016\/j.jcv.2016.06.013_bib0105","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/cid\/cis900","article-title":"An international multicenter performance analysis of CMV viral load tests","volume":"56","author":"Hirsch","year":"2013","journal-title":"Clin. Infect. Dis."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653216301469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653216301469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T22:28:13Z","timestamp":1536618493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653216301469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":21,"alternative-id":["S1386653216301469"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2016.06.013","relation":{},"ISSN":["1386-6532"],"issn-type":[{"type":"print","value":"1386-6532"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-based guidance of foscarnet treatment duration in a transplant recipient with ganciclovir-resistant cytomegalovirus infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2016.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}